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Abstract
Background: Stroke rehabilitation in low- and middle-income countries, such as Mexico, is often hampered by lack
of clinical resources and funding. To provide a cost-effective solution for comprehensive post-stroke rehabilitation
that can alleviate the need for one-on-one physical or occupational therapy, in lower and upper extremities, we
proposed and implemented a technology-assisted rehabilitation gymnasium in Chihuahua, Mexico. The Gymnasium for
Robotic Rehabilitation (Robot Gym) consisted of low- and high-tech systems for upper and lower limb rehabilitation.
Our hypothesis is that the Robot Gym can provide a cost- and labor-efficient alternative for post-stroke rehabilitation,
while being more or as effective as traditional physical and occupational therapy approaches.
Methods: A typical group of stroke patients was randomly allocated to an intervention (n = 10) or a control group
(n = 10). The intervention group received rehabilitation using the devices in the Robot Gym, whereas the control
group (n = 10) received time-matched standard care. All of the study subjects were subjected to 24 two-hour
therapy sessions over a period of 6 to 8 weeks. Several clinical assessments tests for upper and lower extremities
were used to evaluate motor function pre- and post-intervention. A cost analysis was done to compare the cost
effectiveness for both therapies.
Results: No significant differences were observed when comparing the results of the pre-intervention Mini-mental,
Brunnstrom Test, and Geriatric Depression Scale Test, showing that both groups were functionally similar prior to the
intervention. Although, both training groups were functionally equivalent, they had a significant age difference.
The results of all of the upper extremity tests showed an improvement in function in both groups with no
statistically significant differences between the groups. The Fugl-Meyer and the 10 Meters Walk lower extremity
tests showed greater improvement in the intervention group compared to the control group. On the Time Up
and Go Test, no statistically significant differences were observed pre- and post-intervention when comparing the
control and the intervention groups. For the 6 Minute Walk Test, both groups presented a statistically significant
difference pre- and post-intervention, showing progress in their performance. The robot gym therapy was more
cost-effective than the traditional one-to-one therapy used during this study in that it enabled therapist to train
up to 1.5 to 6 times more patients for the approximately same cost in the long term.
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Conclusions: The results of this study showed that the patients that received therapy using the Robot Gym
had enhanced functionality in the upper extremity tests similar to patients in the control group. In the lower
extremity tests, the intervention patients showed more improvement than those subjected to traditional
therapy. These results support that the Robot Gym can be as effective as traditional therapy for stroke
patients, presenting a more cost- and labor-efficient option for countries with scarce clinical resources and
funding.
Trial registration: ISRCTN98578807.
Keywords: Stroke, Rehabilitation, Robot therapy, Affordable, Low-and-Middle Income Countries (LMIC), Upper
limb, Lower limb, Global Health
Background
A stroke is a cerebrovascular accident provoked by
an interruption of the blood supply to the brain or a
rupture of a blood vessel in the brain. Stroke is one
of the leading causes of death worldwide, with over
two-thirds of stroke deaths occurring in developing
countries [1, 2]. According to the World Health
Organization, approximately 15 million people suffer
a stroke each year [3]. In the United States (US),
610,000 new cases are reported yearly [4]. Stroke
rates are expected to increase in the next 40 years as
the aging population in the US expands [5]. In
Mexico, stroke is a major public health issue [6]. It
is the 3rd leading cause of death among people aged
sixty years or older and the fifth leading cause of
death in people aged 15 to 59 years old [7, 8]. It has
been projected that cerebrovascular disease in middle
income countries will be the leading cause of burden
of disease by 2030 [9].
Stroke is one of the leading causes of disability in both
developing and developed countries [10]. Common dis-
abilities after stroke include: hemiparesis, motor deficits,
cognitive deficits, aphasia, proprioceptive deficits and
depressive symptoms [11, 12]. Typically in high-income
countries as the USA, after a stroke, one-third of the
patients are left with a permanent disability that can
range from a mild to a severe, long-term disability [3,
11, 13], while in low-and middle income countries
(LMICs) those with disability will often be more severe
with higher long term economic burden and impact on
society [14, 15]. The economic burden of stroke is
usually classified in terms of medical expenses and
indirect costs due to loss of productivity. It has been
estimated that medical and indirect costs in the US from
2012 to 2030 will increase from 71.55 to 183.13 billion
and 33.54 to 183.13 billion, respectively [16]. While the
cost of medication and therapy in developing countries
may be lower than in developed countries, the average
family income in developing countries is also significantly
lower. For example, the family income of more than
65 % of population in Mexico is around 250 USD a
month, which is insufficient to cover the treatment of
hypertension for just one family member [17]. An-
other significant problem in developing countries is
the lack of trained healthcare personnel, especially
physical therapists in rehabilitation settings. Mexico
has 1,500 physical therapists for a population of
125,000,000 while the ratio of health workers is
about 2.85 personnel per 1000 patients in Mexico
compared to 14.66 per 1000 patients in the US [18].
In addition to the low numbers of therapists and
health workers, the cost of medical equipment,
which includes rehabilitation technology, is higher in
LMICs. These higher costs are due to the minimum
amount of research and development of such equip-
ment that takes place in LMICs and the need to
import foreign medical equipment with marked up
cost incorporating importation taxes and third party
distribution profits [16]. Short supply of trained healthcare
physicians and medical technologies makes access to
rehabilitation facilities and associated services limited
and not affordable to a large part of the population
[19, 20].
Inpatient and outpatient stroke rehabilitation is recom-
mended and is associated with better functional outcomes
after stroke. A wide range of post-stroke rehabilitation
therapies exist to address motor impairments and to
ultimately improve function and independence in the com-
munity [21, 22]. Langhorne et al. systematically reviewed
interventions for motor impairment rehabilitation after
stroke, which include: mixed approach, motor learning,
neurophysiological approaches, bilateral training, biofeed-
back, constraint induced movement therapy, and robotics,
among others [23]. This study concluded that the most
promising intervention for upper-limb function seems to
be constraint-induced movement therapy for the upper
limb and fitness training, high intensity therapy, and re-
petitive task training for gait improvement. In contrast,
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Pollock et al. concluded that there is not enough
evidence to support that one post-stroke rehabilita-
tion therapy is more effective than the others and
suggests that a mix of different rehabilitation therap-
ies may be more effective to improve function and
mobility. In addition, therapies with consistent en-
gagement in 30 to 60 min sessions 5 to 7 days a
week were found to have better outcomes, regardless
of the therapies used [24]. Comprehensive, intensive,
and task-specific therapies are thought to be the most
likely to produce therapeutic effects on stroke pa-
tients [25]. Many of the above strategies are standard
of care in high-income countries, but sparse rehabili-
tation infrastructure and low numbers of rehabilitation
clinicians, make applying these recommendations diffi-
cult in LMICs.
Evidence supports rehabilitation robots’ role in im-
proving rehabilitation outcomes and reducing barriers to
rehabilitation services [26–32]. Rehabilitation Robots
have the potential to narrow the gap between those who
recover and those who do not. Robots can improve func-
tional outcomes, increase access and time of therapy, and
maximize resources in a variety of rehabilitation environ-
ments [28, 29, 31]. Examples of these systems include the
Lokomat (Hocoma, Inc) for lower limb gait therapy [30]
and ARMin [33], MAHI Exo II [34], T-WREX [35] precur-
sor of the commercial Armeo Spring (Hocoma, Inc) and
InMotion Robots (Interactive Motion Technologies)
[27, 32] for upper limb therapy. They are characterized
by the use of a multi-degree of freedom robot manipu-
lator for training the impaired arm of the patient and
guiding the person through therapeutic exercises ran-
ging from point-to-point reaching to real activities.
Forces are applied as needed to assist the patients to
move when they are unable to move independently or
self-correct their movement. Meta-analyses and clinical
trials show that rehabilitation outcomes with robots are
comparable to standard and intensity-matched stroke
rehabilitation and significantly improve functional out-
comes in terms of motor control and ADL function
[28, 29]. The use of robotic therapy has also been
proven to be promising in its potential cost savings and
efficient use of the therapists’ working time, throughout
the labor-intensive and long-term process of stroke re-
habilitation [36, 37]. Wagner and colleagues suggest
that after 36 weeks, the total costs of robot therapy
were comparable for the three groups they trained
“($17,831 for robot therapy, $19,746 for intensive com-
parison therapy, and $19, 098 for usual care)” [32].
Hesse and colleagues demonstrate that robot circuit
training may ultimately result in a 50 % savings over in-
dividualized training (cost per treatment session were
4.15 Euro versus 10.00 Euro) [26].
Most robot-assisted therapy devices are expensive with
cost greater than 50,000 to 100,000 USD for a single unit
[32]. However, more recent affordable systems are being
proposed for the home and rehabilitation facilities use
such as Reha-Stim line of devices [38, 39], TyroMotion’s
Pablo® [40], Hand Mentor Pro™ from Kinetic Muscle, Inc.
[41], and Haptic Knob [42] among others. In Germany, a
suite of simple robots arranged in the ARM Studio was
able to improve functional outcomes after stroke for pa-
tients in an inpatient rehabilitation center [43]. In the
USA, a suite of simple computer/robot technologies was
able to assess and improve functional outcomes of the
upper limb [44]. These studies suggest that affordable
technology solutions for rehabilitation may provide the
means to bridge the gap between the scarcity of rehabilita-
tion providers and their growing disabled population in
LMICs. Very few studies have critically examined the issue
of accessible post-stroke rehabilitation and have attempted
to implement cost-efficient rehabilitation alternatives in
LMICs, such as Mexico. Hence, the goal of this study was
to develop and deliver an effective and cost and labor effi-
cient method of post-stroke rehabilitation that encouraged
continued rehabilitation and was more or as effective as
traditional physical and occupational therapy approaches.
This paper describes a pilot randomized controlled trial
where patients were allocated to receive traditional ther-
apy (control) or Robot Gym therapy. We report pre- and
post-clinical results on assessment tests for the upper and
lower limbs after 24 sessions of therapy with the Gym.
The Robot Gym created an affordable stroke therapy
clinic utilizing the TheraDrive robot [45–47] and other
similar low-cost technologies in combination with game
therapy. This post-stroke treatment concept is unique in
that it combines a wide-range of assistive and robot tech-
nologies. In addition, it supports that a viable, accessible
rehabilitation solution can include affordable robots along
with other cost-efficient rehabilitation technologies.
Methods
Protocol description
The goal of this pilot study is to evaluate the effectiveness
of a stroke intervention protocol implemented via a low-
cost robotic gym (Robot Gym) used in under-supervised
conditions. In this parallel designed protocol, a typical
group of chronic stroke patients were randomized to re-
ceive rehabilitation using the devices in the rehabilitation
robot suite (intervention group; n = 10) or to receive time-
matched standard care (control group; n = 10) at the
Rehabilitation Center in Chihuahua, Mexico (CREE, Centro
de Rehabilitacion y Educacion Especial). Patients were con-
sented and then evaluated by clinicians to assess motor im-
pairment in the upper and lower limbs. As standard of
care, all of the patients at this center go through psycho-
logical evaluations; these medical charts were requested to
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help determine eligibility. The sample size for this pilot
study was 12 patients per group, a convenient sample size
allowing for additional 25 % patients to account for drop
out, resulting in a total of 30 subjects. It was foreseen that
recruitment could be a possible problem due to inaccurate
or missing patient’s clinical history records.
Potential subjects were interviewed and prescreened
by rehabilitation physicians. If a patient was eligible, he
was invited to participate by the physician. Patients in-
terested in participating in this protocol subsequently
met with the principal investigator and the purpose of
this study was explained. All patients were informed
about the potential risks that could be presented during
the study, which include: frustration in being unable to
complete some steering tasks, fatigue, discomfort due
the equipment position, muscle soreness in legs and
arms due to exercise, irritation or pressure sores due the
use of FES, allergic reactions to the electrodes, and a
swelling of the extremities involved on the exercises. All
study participants gave informed consent prior to formal
enrollment in the protocol and were assigned a consecu-
tive number as they were admitted. For example, the first
patient enrolled was assigned number P1; the following pa-
tients were assigned consecutive numbers according to
their recruitment (P2, P3, P4…). An allocation sequence
was generated using the Epidat 4.0 software to randomly
assign numbers from 1 to 30 into two groups: the control
group (CT) or the robotic or intervention group (RT) [48].
All study participants signed an informed consent and
a privacy form. The protocol, the recruitment form,
authorization for release of protected health informa-
tion (PHI), and the informed consent with the registra-
tion number HR-2110, were reviewed and approved by
the Marquette University Institutional Review Board
(IRB) and the CREE ethics committee.
Subject population
All patients assessed for eligibility were clinically diag-
nosed with hemiplegia from a stroke occurred more than
6 months prior the study. Prior to the study, clinical evalu-
ations were performed by certified clinicians and physiat-
rist on all subjects to determine their impairment in their
extremities, their functional disability, and their cognitive,
and depression levels. All of the subjects were included in
this study if they were 1) between 21 and 75 years; 2) had
hemiparesis due to a cerebral vascular accident (CVA)
stroke (confirmed by a physician); 3) were at least 6-
months post-stroke and medically stable; 4) had the ability
to sit for 60 min and to stand, assisted or unassisted, for
30–40 min; 5) had a score less than eight in the Geriatric
Depression Scale [49] indicating mild depression and a
likelihood of completing the 24 sessions required; 6) were
no be more than moderately cognitively impaired as
defined by a Mini-mental Test [41] score greater than
20–they were able to give consent and understand in-
structions; 7) had residual movement in shoulder flexion/
adduction and active elbow flexion/extension and/or re-
sidual movement in leg flexion/extension and hip adduc-
tion as defined by a Brunnstrom Test Score [39] ranging
from 2 to 5; and 8) had a muscle strength scores on the
Manual Muscle Test [50] between >1 and <3 in both ex-
tremities. All of the subjects included in this study passed
the inclusion criteria above. They had their left side af-
fected and had low and medium impairment.
Subjects were excluded if they 1) had excessive spasticity
in upper and lower limbs as measured by the Ashworth
scale [51] over 4; 2) had pain exceeding 4 on a visual ana-
log pain scale [52, 53]; 3) had total paralysis or muscular
contractures of upper or lower extremity; 4) had a history
of psychiatric disorder or cardiac problems; 5) had me-
tallic implants near electrical stimulation site or cardiac
defibrillators implants; 6) were pregnant or breast feeding;
and 7) they were unwilling to participate or comply with
the protocol.
Interventions
All study participants were subjected to 24 two-hour
therapy sessions over a period of 6 to 8 weeks.
The CT group received standard rehabilitation therapy,
which includes personalized physical and occupational
therapy usually in a one-on-one therapist to patient ratio.
Standard rehabilitation therapy includes manual mobiliza-
tions, heat, ultrasound, therapeutic TENs (transcutaneous
electrical nerve stimulation), and repetitive tasks for occu-
pational therapy using tools such as balls, cone sets, exer-
cise bands, among others. All of the patients repeated the
clinical evaluations post-therapy. It is important to note
that the control group here experienced the standard of
care for 2 hours in order to time-match the therapy given
to the robot group. Typically patients at CREE would ex-
perience only 30 min of the standard of care therapy.
Robot Gym therapy consists of six stations of com-
puter and motor assisted devices to aid in the motor re-
habilitation of the upper and lower extremities, as well
as cognitive improvement. The stations are distributed
based on a closed circuit structure (Fig. 1), so that when
the patient finishes an activity in a station, they can go
to the next station without having to walk a long dis-
tance. Subjects in the RT group switched stations in the
Robot Gym every half hour, working on four stations
per day throughout the 24 sessions in order to achieve
an equal number of therapy sessions in each station. The
following describes the stations.
Station A. TheraDrive: A low cost system for person-
alized arm rehabilitation based on the theradrive robot
was developed [46]. Theradrive targets upper limb
dynamic exercises aimed at strengthening and ranging
the elbow and shoulder. This device allows patients to
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play custom-made games and commercial videogames
with a Logitech wheel. The wheel can be placed in
front of the person or sideways at different angles and
heights. For this protocol, the wheel was mounted in
front of the person at a 20° angle and centered on the
person’s midline. The wheel’s height was adjustable by
15 cm so that the height would be placed for each pa-
tient’s comfort. The force-feedback settings on the
wheel can be programed to help or disrupt the movement
in the upper limbs. These force settings were adapted ac-
cording to the patient’s initial functional level, i.e., assistive
forces were set if the patient was lower functioning, which
meant the patient scored lower than 23 points on the Fugl
Meyer upper extremity test. Assistive forces decreased
and disruptive forces increased as the patient performance
improved. The purpose of these settings was to keep pa-
tient working at a level that required effort to improve his
functionality but to avoid frustration.
Station B and C. NESS H200 and NESS L300: These
Bioness devices rehabilitate hand function and foot
function, respectively. The NESS H200 (Station B) is a
commercial hand rehabilitation system that provides
functional electrical stimulation (FES) to help open and
close a patient hand while performing functional daily
activities as grab, pile and move different objects [54].
The NESS L300 (Station C) is a commercial foot-drop
system using FES to assist dorsiflexion to help improve
the patient’s gait [54, 55]. Both devices have the capacity
to improve voluntary movement of the injured limbs and
help with the reeducation of the muscles generating neu-
roplasticity. The levels of intensity used during electrical
stimulation vary between level 5 to 9 and was dependent
on the patient tolerance and response to stimulation. The
level was adjusted to achieve dorsiflexion without causing
intolerable discomfort sensation due to the stimulation.
Station D and E. MOTOmed viva2 LE and MOTOmed
viva 2 UE: These MOTOmed devices rehabilitate the
lower and upper limbs, respectively. The MOTOmed
viva2 LE (Station D) is a commercial lower extremity
motor assisted device that allows passive or active resist-
ance training through a series of simple games similar to
bicycling [56]. The MOTOmed viva 2 UE is a commercial
upper extremity motor assisted device that allows passive
or active resistance training through a series of simple
games for movement therapy [57]. Both of these devices
provide individualized options and biofeedback which are
determined by the physician and therapist according to
each patient’s abilities. During the study, the main purpose
of these devices was to improve the symmetry of upper
and lower extremities and motivate the patient to involve
their affected limb in the tasks. Their system provides real
time feedback about the usage percentage of left and right
limb respectively, with the maximum level of resistance
tolerated by the patient.
Fig. 1 Distribution of the stations inside facility at CREE Chihuahua. Beginning by the door, clockwise, is: the Theradrive system in the first station;
the Ness for upper extremity in the second station; the Ness for lower extremity in the third station; the Motomed Viva 2 for upper extremities in
the fourth station; the Motomed Viva 2 for lower extremities in the fifth station; and Capitain’s Log Brain-trainer in the sixth station
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Station F. Captains Log Brain Trainer: This commer-
cial Cognitive Rehabilitation Therapy System provides
systematic brain training to patients with brain injury
and aims to improve neuroplasticity. It focuses on train-
ing different cognitive domains such as memory, atten-
tion, perception, reasoning, planning, judgment, general
learning and overall executive functioning through com-
puter games. This program has three levels of difficulty
(silver, gold and diamond) and an initial test is given to
the patient to assess the cognitive state of the patient
and assign an initial level of difficulty. The software
automatically will increase or decrease difficulty accord-
ing to patient performance. The Log Brain trainer was
adapted to a joystick to allow patients with decreased
hand control to manipulate the interface and to promote
work on motor visual skills [58].
Clinical assessments
Upper and lower limb assessments were conducted before
and after the 24 sessions of therapy. The Fugl-Meyer
Upper Extremity Test (UE-FM) [59–61], the Rancho Los
Amigos Functional Test for the upper extremity (UE-FT)
[62], and the Box and Block Test (BBT) [63] were used for
upper limb assessments. The UE-FM measures several pa-
rameters of upper limb function in stroke patients. The
physiatrist measured reflex ability, speed, coordination,
flexion, and extension synergy through various exercises.
These exercises were scored from 0 to 2, where 0 is an ex-
ercise that could not be performed, 1 is an exercise that
was partially done, and 2 is that the exercise performed
without failure. The maximum score a patient could
achieve is 66– the higher the score, the lower the degree
of impairment [59–61]. The UE-FT evaluates the inte-
grated function of the total upper extremity in adult pa-
tients with hemiparesis. It is arranged in seven levels and
administered in approximately 30 min. The higher the
level, the lower the degree of impairment [62]. In the BBT,
the patient is asked to move wooden cubes from one side
of a divided box to the other. If the right limb is analyzed,
the patient must move the cube from right to left and vice
versa. The objective is to measure patient’s grip when
holding the cube, lifting the arm, and crossing through
the division in the box to place the cube on the other
side [63].
The Fugl-Meyer Lower Extremity Test (LE-FM) [64–66],
the 6-minute Walk Test (6MinWT) [67, 68], the 10-meter
Walk Test (10MtsWT) [66], and the Timed Up and Go
Test (TUG) [69] were used for lower limb assessments.
The LE-FM is similar to its counterpart for the upper limb;
various parameters of lower limb function in a post-stroke
hemiplegic patient are measured. The physiatrist measured
lower limb reflex ability, speed, coordination, flexion, and
extension synergy through various exercises. The maxi-
mum score is 34–the higher the score, the lower the degree
of impairment [64–66]. The 6MinWT measures the dis-
tance the patient can walk in 6 min. A longer distance
walked in the final test compared to the initial test indi-
cates an improvement [67, 68]. The purpose of this test is
to assess functional exercise capacity or aerobic capacity
endurance. The 10MtsWT measures the time it takes the
patient walk 10 m. A shorter time in the final test com-
pared to the initial test indicates an improvement [66]. The
objective of this test is to evaluate functional mobility. The
TUG measures the time it takes a patient to get up and
walk 3 m beginning at a seated position. A shorter time to
execute the task in the final test compared to the initial test
indicates improvement [69].
Data analysis and statistics
Clinical assessment data was collected before and after
the 24 sessions of therapy. The assessments were divided
into qualitative and quantitative assessments. The quan-
titative tests included: the Fugl-Meyer Upper and Lower
Extremity Tests, the 6-minute Walk Test, the 10-meter
Walk Test, the Time Up and Go Test, and the Box and
Blocks Test. The qualitative test is the Functional Test.
Subjects were divided into therapy groups, Robot Gym
(intervention group, RT) and traditional therapy (control
therapy, CT). The pre- and post-assessments of each
group were compared to determine if there were changes
after the 24 sessions of therapy. Quantitative assessments
were analyzed using a Student’s t test; a level of p-value
of ≤0.05 was considered statistically significant. The
Anderson-Darling normality test to verify Gaussian dis-
tribution was performed. Bartlett test was performed to
verify the equality of the variances between the groups.
For p-values >0.05 in the Bartlett test or the Anderson-
Darling test, we considered the p-value of the Student’s
t parametric test. If this test showed no homogeneity
and unequal variance, i.e., p-values ≤0.05 in either test,
the Kruskal-Wallis non-parametric test was used. We
also calculated the effect size for the RT and CT inter-
vention using the Cohen d value [70]. Qualitative tests
were analyzed using Single Table Analysis; a level of p-
value of ≤0.05 was considered statistically significant.
Therapies cost-effectiveness analysis
To evaluate the cost-effectiveness of the robot gym with
respect to traditional therapy, we used the formula re-
ported by Hesse and colleagues (see Eq. 1) to calculate the
cost of therapy per session [26]. Equation 1 calculates
therapy cost per session by dividing the total number of
patients treated by a therapist in a year into the treatment
operating expenses, which is the sum of the one-time
equipment cost. the yearly maintenance cost of the equip-
ment and the yearly cost of employing the therapist(s) per
year [26]. The labor efficiency was taken to be the ratio of
therapist needed to patient treated per year.
Bustamante Valles et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:83 Page 6 of 15
The prices of the robotic equipment were taken at the
time of purchase and the maintenance cost was esti-
mated to be about 25 % of original cost. The staff cost
was based on the therapist salaries reported by the
Mexican health minister (Secretaría de Salud) [71]. The
Stroke guidelines, which is published by the Minister of
Health in Mexico, recommends therapy sessions of 3 to
7 days a week, from 20 to 60 min per day, with a re-
habilitation specialized therapist and there are no writ-
ten recommendations for group therapies. The CREE
has 278 working days in a year. The mean number of pa-
tients that can be treated by one therapist in 1 year for
the standard of care was reported by the lead therapist
at CREE. This treatment number was calculated two
ways for traditional therapy: 1) based on therapy session
duration experienced by the control group in the proto-
col, which was two hours in order to time-match the
therapy given to the robot group and 2) based on the
session duration typically experience by patients at
CREE, which is 30 min of the standard of care therapy.
Since our study took place in Mexico, the cost analysis
was made in Mexican pesos but we included an approxi-
mation of US dollars considering the mean exchange
rate in 2011.
Results
The recruitment period lasted from January 2012 to
September 2013. The participant flow is described in
Fig. 2. Twenty-seven patients were recruited. Seven patients
left the protocol due to different reasons, including the
presence or relapse of an illness unrelated to the study, lack
of interest in the assigned therapy, and personal reasons.
Table 1 presents a summary of the subject demographics.
The pilot trial recruitment stopped at a sample size of
10 in each group because both groups had the same
sample size and other new patients who accomplish all
the inclusion criteria were not available.
The mean age of the study participants per group is
shown in Table 2. The inclusion criteria measurements
made prior to the intervention to ensure study partici-
pant homogeneity were the following: the Mini-mental
Scale Test (Table 3), the Geriatric Depression Scale Test
(Table 4), and the Brunnstrom Test (Table 5). Although
the RT group was significantly younger than the CT
group (RT:44.1 ± 12.55 versus CT:64.1 ± 8.38; p <0.0006),
both groups had comparable cognitive function assessed
using the Mini-mental Scale Test (RT:28.5 ± 2.01 versus
CT:27.6 ± 2.72; p <0.411), mental health assessed by the
Geriatric Depression Scale (Table 2; p = 0.401) and initial
motor function assessed by the Brunnstrom test (Table 3;
p = 0.5724). The Geriatric Depression Scale measures
mental health using a scale from 1 to 8 according to
their emotional status. The Brunnstrom Test qualitatively
classifies subjects using a scale from 1 to 5 according to
their muscular movement impairment.
Upper extremity assessment results
The pre- and post-intervention scores for the Fugl-Meyer
Upper Extremity Test (UE-FM) and Box and Block Test
(BBT) are shown in Table 6. The change generated after
the intervention is also shown. Both groups showed
improvement with a UE-FM score that increases more
than 4 points post-intervention (RT: 4.6 ± 3.89 and CT:
5.1 ± 4.72). No statistically significant differences in
improvement were observed when comparing the two
groups (p = 0.799), suggesting that each intervention
was equally effective. Although not statistically significant,
the RT group showed more improvement in the BBT
scores than the CT group (RT: 2.2 ± 3.61 and CT: −0.3 ±
3.30; p = 0.124). Overall, there was improvement in both
groups. Effect size calculations show that both RT group
and CT group had a small effect (0.34 and 0.25, re-
spectively) on UE-FM, whereas the RT group had
higher effect on BBT outcomes (0.23) compared to the
CT group (−0.03).
The results of the Functional Test for the upper ex-
tremity (UE-FT) are shown in Table 7. The score row
shows the possible UE-FT score where the patient can
be assigned. As shown with the UE-FM and BBT, both
groups improved. The change column score displays
how many subjects changed score levels after the inter-
vention. For example, in the RT group, one subject de-
creased two levels, two subjects improved one level, two
subjects improved three levels, and five subjects did not
change. No statistically significant differences were
found when comparing the RT and CT group pre- and
post-intervention.
Lower extremity assessment results
The clinical change results for the lower extremity
assessment using Fugl-Meyer Lower Extremity Test
(LE-FM), 6-minute Walk Test (6MinWT), 10-meter
Therapy Cost=Session ¼ Equipment and Mainteinance Costsþ Therapist
0s Annual Salary
# of patients treated in a year
ð1Þ
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Walk Test (10MtsWT) and Timed Up and Go Test
(TUG) are shown Table 8. When comparing the pre-
intervention LE-FM, no significant difference was ob-
served between the two groups (RT: 23.1 ± 6.37 and
CT: 20.1 ± 5.78; p = 0.284). After the intervention, both
groups showed improvement, with the RT group present-
ing a significantly greater improvement compared to the
CT group (RT: 26.4 ± 4.70 and CT: 20.6 ± 6.41; p = 0.033).
Fig. 2 Flow diagram of study participants. This diagram shows the participant flow since recruitment until the information analyses. It also
includes the care providers who provided the assigned therapy to each group. Based on recommended flow diagram by CONSORT Group on
Nonpharmacologic Treatments [85]
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The change in the RT group was on average of 2.8 points
greater than the CT group. Effect size calculations show
that the intervention had a moderate effect (0.59) on LE-
FM outcomes in the RT group and little to no effect in the
CT group (0.08). This moderate effect was not observed in
the 6MinWT, 10MtsWT or TUG functional outcomes.
The 6MinWT and 10MtsWT functional walking tests
demonstrated the improvement seen. An increase in dis-
tance walked in 6MinWT indicates improvement, whereas
a decrease in time in 10MtsWT indicates improvement.
For the 6MinWT, the RT and CT group show a statisti-
cally significant difference pre- and post-intervention with
both groups presenting progress in their performance.
Due to the large variability within the groups, the changes
seen in the RT group (13.5 ± 35.96) were not significantly
greater than those in the CT group (1.8 ± 15.80). A large
variability in individual performance was also observed in
the 10MtsWT. Despite a large mean score difference,
there were no statistically significant differences observed
when comparing the groups pre-intervention; however,
the post-intervention 10MtsWT times were statistically
different when comparing the groups. The RT group im-
proved with a reduced time to perform the task of 4 s, but
the change differences in this group were not significant
due to the large standard deviations seen in perform-
ance. The groups did not have statistically significant
differences when comparing the pre-intervention TUG
times (p = 0.06). A decrease in the TUG test time indi-
cates improvement. The average time to TUG in the
RT group decreased after the intervention, but the aver-
age time in the CT group slightly increased. However,
Table 2 Mean age of study participants according to group
Group Age
Robotic (n = 10) 44.1 ± 12.55
Control (n = 10) 64.1 ± 8.38
P Value 0.00055
Table 1 Subject pre-intervention information
Patient Age Sex Group Brunnstrom level Mini-mental state
examination
Geriatric
depression scale
Fugl Meyer
upper extremity
Fugl Meyer
lower extremity
Robot Gym Group
P3 59 M RT 4 28 3 33 31
P4 44 F RT 3 29 3 23 12
P5 52 M RT 5 23 1 51 27
P6 40 F RT 2 29 7 21 28
P7 25 F RT 4 30 3 30 30
P9 29 F RT 2 29 4 9 21
P10 33 F RT 3 29 0 19 23
P12 44 M RT 3 29 5 17 21
P13 62 F RT 3 29 1 8 14
P17 53 F RT 3 30 2 19 24
Control Group
P8 71 F CT 2 28 1 15 15
P11 74 M CT 2 28 5 7 19
P14 54 M CT 3 28 1 4 15
P16 49 F CT 3 30 5 23 26
P18 69 M CT 4 21 2 47 25
P20 69 F CT 3 29 2 5 12
P21 56 F CT 2 29 6 18 24
P22 69 M CT 2 25 8 6 16
P24 62 F CT 3 30 2 58 26
P27 68 F CT 3 28 4 37 29
IT and CT refer to intervention therapy (Robot Gym) and control therapy, respectively. This table shows the baseline of different tests for each patient that
concluded the protocol
Table 3 Mean scores of pre-intervention mini-mental scale test
results according to group
Group Pre-intervention mini-mental scores
Robotic (n = 10) 28.5 ± 2.01
Control (n = 10) 27.6 ± 2.72
P Value 0.411
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the changes seen in these values were not significantly
different.
Cost comparison
Traditional therapy staff costs were calculated using sal-
aries of therapists. The salary of a rehabilitation special-
ized therapist in the Mexican public health institution is
reported to be around $235,344 MXN ($19,612 USD)
per year. It was assumed that the initial cost of the exist-
ing traditional therapy equipment, which is about 7,000
USD, is irrelevant since our intention is to augment the
existing rehabilitation centers with robotic therapy. As
such, only a maintenance and consumables fee per year
was added to salaries. For the typical standard of care at
CREE, and in fulfillment with Mexican therapy guide-
line, a therapist can attend up to four patients in a
period of time of 2 h, which translates into 16 patients
in a full 8-h work day. For the 278 working days at
CREE this translates to 4448 patients in a year. For the
control group in this protocol where standard of care
was time-matched to the robot gym, therapists treated
one patient for 2 h. This would equate to four patients
per day in a full-time shift of 8 h and, for the 278 working
days at CREE, about 1112 patients per year.
For the robot gym therapy numbers the staff cost for a
rehabilitation specialized therapist was assumed to be
the same as in the traditional therapy. The robot gym
equipment was acquired in USA and imported to
Mexico. The full cost of the robotic equipment (adding
transportation and importation costs) is $432,592.4
MXN, to be settled within 2 years with annual payments
of $216,296 MXN (approximately $18,024 USD at that
time). A 25 % overhead was added into the numerator of
the equation for maintenance and consumables, giving
us $108,148 MXN. The number of patients seen in a
session was dictated by the gym design. The design of
the Robot Gym allows six patients to be supervised and
receive 2 h of therapy, which translates in 24 patients a
day, in a full-time shift of 8 h and, for the 278 working
days at CREE, about 6672 patients per year.
Table 9 summarizes the variables these results. Tradi-
tional therapy, which consisted of the time-matched
standard of care where patients received 2 h of therapy,
was estimated to have therapy cost of $230.52 MXN
($19.21 USD) per session with the labor ratio of 1 to
1112 per year. Traditional therapy, which consisted of
the standard of care where patients received 30 min of
therapy per session, was estimated to have a therapy cost
of $57.63 MXN ($4.80 USD) with the labor ratio of 1 to
4448. In contrast, the robotic therapy group, the therapy
cost would be $83.90 MXN ($6.99 USD) within the first
2 year and after this period of time, the net cost of the
equipment will be liquidated and only the percentage re-
served for the maintenance will remain, reducing the
cost to an estimated cost for robotic therapy of $51.48
MXN ($4.29 USD) per session with a 2 h therapy session
per patient. The labor ratio is 1 to 6672 per year.
When treatment time is matched, the robot gym
would allow six times more patients to be seen than
time-matched standard of care for the control group and
1.5 times more than what is typically done in CREE. The
robot gym therapy would deliver more time for therapy
at the same cost as what is currently being done in the
one-to-one traditional therapy. The cost of providing the
time-matched traditional therapy would be 2.74 more
expensive than using the robot gym in the first 2 years
increasing to about 4.5 times more expensive thereafter.
Discussion
Given the need for affordable alternatives to post-stroke
rehabilitation and the lack of physical and occupational
therapists in developing countries, we proposed and
Table 4 Pre-intervention depression scale scores
Group Pre-intervention depression scores
# of Patients given a score
Possible depression scale scores 0 1 2 3 4 5 6 7 8
Robotic 1 2 1 3 1 1 0 1 0 Sum of col. = 10
Control 0 2 3 0 1 2 1 0 1 Sum of col. = 10
Chi-Squared Value 8.33
P Value 0.401
The possible scores are the values the patients could archive. Thus, this test is qualitative. The numbers shown in the robotic and control rows are the number of
patients that were given that possible score in its column pre-intervention. For example, one patient in the RT were given the score of “0” and no patient in CT
was given the score of “0”
Table 5 Pre-intervention Brunnstrom test results
Group Pre-intervention Brunnstrom Scores
# of Patients given a score
Possible Scores 2 3 4 5
Robotic 2 5 2 1 Sum of col. = 10
Control 4 5 1 0 Sum of col. = 10
Chi-Squared Value 2
P Value 0.572
As the Brunnstrom Test is a qualitative test, the numbers shown on the
robotic and control rows represent the number of patients that were given
the possible score in its column
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developed a Gymnasium for Robotic Rehabilitation. This
system combines relatively low cost robotic therapy with
intensive, task-specific therapies for both the lower and
upper extremities. The Robot Gym introduces a combin-
ation of semi-independent therapies using a circuit-
training concept and adding Functional Electrical Stimu-
lation, cognitive, and gaming therapy that target activ-
ities of daily living. Circuit class or circuit training
therapy uses different physical activity workstations
combined in an intensive manner, involving more than
two patients per therapist [72]. CCT provides a cost sav-
ing option reducing the staff to patient ratio and has
been proven to be effective in improving walking cap-
acity and mobility [73, 74]. Accumulating evidence sup-
ports that gaming therapy, the use of electronic games
in rehabilitation settings, is more enjoyable and accepted
by patients [75].
The data generated in this pilot study shows that the
Robot Gym is a cost- and labor-efficient alternative for
post-stroke rehabilitation. The results from the lower
extremity tests (LE-FM, 6MinWT and 10MtsWT) sup-
port that the Robot Gym may be more effective or as ef-
fective as traditional physical and occupational therapy
approaches. Subjects in the RT group significantly im-
proved an average 3.3 points in the Fugl-Meyer Lower
Extremity Test scores compared to the CT, which had
an average improvement of 0.5 points (p = 0.033). The
effect size in the LE-FM scores support that robotic
therapy may be more effective than traditional therapy
(0.59 versus 0.08). The same tendency seen in the Fugl-
Meyer Lower Extremity Test, was observed in 10-meter
Walk Test. The RT group walked faster, with a reduction
of an average of 4.2 s, in contrast to the CT group,
which took an average of 2.12 s longer to complete the
10 meter walk. In the post-intervention 6-minute Walk
Test, the RT group walked an average 13.55 m more
compared to the control group that walked an average
1.85 m more in the 6 min time frame. The statistically
significant differences observed between the groups
when comparing the post-intervention 10-meter Walk
Test and 6-minute Walk Test results suggest that ro-
botic therapy administered via the Robot Gym may be
more efficient than traditional therapy. These results are
supported by the evidence presented by Buschfort and
colleagues [35] and Hesse and colleagues [26] showing
the effectiveness of circuit training using robots in a re-
habilitation hospital in Germany, a high income country.
Our results support the use of robots in this manner
and show that it has the potential to augment access is-
sues in middle income countries such as Mexico.
Both intervention groups were functionally similar
prior to the intervention according to the clinical test
but not in age. All of the pre-intervention test results
showed a no statistically significant differences between
groups, with the exception of the 6-minute Walk Test.
A statistically significant difference in pre- and post-
intervention 6-minute Walk Test results between the
groups with a p-value = 0.036 and a p-value = 0.0254,
respectively. The difference between groups could be
explained by the origin of this test. The 6-minute Walk
Test was developed as a tool to measure functional car-
diopulmonary capacity [67]. As the cardiopulmonary
capacity declines with age [76, 77], the difference could
be due the age difference between the groups. The sub-
jects in the CT group were on average older than those
in the RT group (p-value = 0.0005). The inclusion
Table 6 Upper extremity test results
Upper Limb Scores Group Pre Post Effect size (Cohen’s d) Change
Fugl-Meyer (UE-FM)
Max score is 66
Robotic (n = 10) 23 ± 12.59 27.6 ± 14.70 0.34 4.6 ± 3.89
Control (n = 10) 22 ± 19.17 27.1 ± 22.03 0.25 5.1 ± 4.72
P Value 0.891 0.953 0.799
Box and Block
(BBT)
Robotic (n = 10) 3 ± 8.46 5.3 ± 11.28 0.23 2.2 ± 3.61
Control (n = 10) 4.7 ± 9.45 4.4 ± 7.26 −0.03 −0.3 ± 3.30
P Value 0.676 0.834 0.124
The Fugl-Meyer (UE-FM) maximum score is 66.BBT is in # of blocks in 1 min
Table 7 Functional test scores
Group Pre Post Change
Possible FT Scores 1 2 4 5 6 7 1 2 4 5 6 7 −2 0 1 2 3
Robotic 0 6 3 0 1 0 #10 0 5 0 4 1 0 #10 1 5 2 0 2
Control 3 3 2 1 0 1 #10 2 4 1 1 0 2 #10 0 7 2 1 0
Chi-Squared 8.33 8.05 4.33
P Value 0.401 0.089 0.362
The possible score row shows the possible values a patient could achieve in this test
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criteria tests that included the Mini-mental, the Brunn-
strom Test, and the Geriatric Depression Scale tests
were not significantly different between the groups.
Therefore, both groups were considered functionally simi-
lar before the intervention. The age difference could be at-
tributed to the size of the sample and the wide age range,
21 to 75 years old, in the inclusion criteria. Although func-
tionally equivalent at onset of the treatment, the signifi-
cant differences in age across study groups may limit the
interpretation of the results. The effect of age should be
considered in further studies to corroborate our findings.
Other past studies have found that there is a small effect
of age in stroke recovery, however this effect has been
reported to be of minimal clinical relevance in other
stroke rehabilitation studies [78, 79].
The results of the upper extremity tests suggest that
the robotic intervention administered via the Robot
Gym was as effective as traditional physical and occupa-
tional therapy approaches. The robotic and traditional
therapy interventions had similar effect sizes (0.34 versus
0.25). No statistically significant differences were ob-
served for the Fugl-Meyer Upper Extremity Test when
comparing the groups pre- and post-intervention. The
RT and the CT group improved an average of 4.6 points
and 5.1 points, respectively. Similar results were ob-
served for the Box and Block Test and Functional Test
for the upper extremity, where both groups did not
have statistically significant differences pre- and post-
intervention. The Box and Block Test scores did indi-
cate that the robotic therapy tended to have had a
larger effect on grasping function than the conventional
therapy. More subjects would need to be tested to con-
firm this trend. The conclusion that the robotic inter-
vention was as effective as traditional physical and
occupational therapy coincides with previous reports
about robot-assisted therapy and the Theradrive system
[27, 80–83]. These studies observed an improvement in
functionality and motor recovery of upper extremity, but
the results were not statistically different between groups.
Our study had a small sample size of chronic stroke sur-
vivors, which can be a limitation in our analyses, as it
causes an imbalance on the mean age of the groups and
should be taken into account. Therefore, we must be cau-
tious in the interpretation of the results. Studies in low-
and middle-income countries are often hampered by poor
record keeping. In our study for example, patients are usu-
ally discharged after 3 months of therapy. In public health
centers in particular, records are not kept up to date after
patients are discharged. Because of this, our sample size
was limited and the age range of the patients in the inclu-
sion criteria had to be kept wide to allow for more patients
to participate in the study. Despite this sample size limita-
tion, the significance and effect sizes observed suggest that
therapy administered via the Robot Gym is more or as
Table 8 Lower extremity test results
Lower Limb Scores Group Pre Post Effect size (Cohen’s d) Change
Fugl-Meyer (LE-FM)
Max score is 34
Robotic (n = 10) 23.1 ± 6.37 26.4 ± 4.70 0.59 3.3 ± 3.59
Control (n = 10) 20.1 ± 5.78 20.6 ± 6.41 0.08 0.5 ± 1.71
P Value 0.284 *0.033 *0.035
6 Minute Walk Test
(6MinWT) (meters)
Robotic (n = 10) 214.6 ± 118.46 228.1 ± 126.53 0.11 13.5 ± 35.96
Control (n = 10) 105.5 ± 95.51 107.4 ± 92.42 0.02 1.8 ± 15.80
P Value *0.036 *0.025 0.226
10 Meter Walk Test (10MtsWT)
(seconds)
Robotic (n = 10) 30.9 ± 37.25 26.7 ± 26.20 −0.13 −4.2 ± 13.75
Control (n = 10) 71.9 ± 52.33 74.1 ± 62.25 0.04 2.1 ± 30.57
P Value 0.058 *0.019 0.496
Timed up and Go (TUG)
(seconds)
Robotic (n = 10) 34.9 ± 37.52 31.6 ± 33.05 −0.09 −3.3 ± 6.75
Control (n = 10) 77.1 ± 54.97 78.8 ± 63.39 0.03 1.7 ± 19.21
P Value 0.060 0.051 0.820
*p <0.05 is significant
Table 9 Therapies cost analysis
2 h Therapy 30 min Therapy
Treated patients per year Cost per therapy Treated patients per year Cost per therapy
Traditional Therapy 1112 $19.21 USD 4448 $4.80 USD
Robot Gym Therapy 6672 $6.99 USD N/A N/A
Robot Gym Therapy After 2 years 6672 $4.29 USD N/A N/A
The table shows the cost of both therapies considering the number of patients that can be assessed giving a traditional 30 min session and a 2 h session
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valuable as traditional therapy. However, it is important to
mention that we are only evaluating the short term effect
of the therapy and not the long term effect.
The fact that the robotic gym therapy is cost-efficient
with a favorable labor ratio could play an important role
in the future of the implementation of this new concept.
As for the initial investment in equipment, traditional
therapy settings may include a therapeutic ultrasound,
transcutaneous electrical nerve stimulation, laser ther-
apy, and mechanotherapy equipment. The costs can vary
depending on the complexity of the equipment, but an
approximate cost of 7,000 USD is common. The cost
of building the Robot Gym, including the commer-
cially available equipment and the low-cost custom
built equipment, was approximately 45,000 USD paid
over 2 years. Even though the Robot Gym was de-
signed to be low cost, it exceeds the initial cost of a
traditional rehabilitation setting, which is usually the
case with the use of actual robots and has been re-
ported in the literature [32]. However, viewing the results
of the cost analysis comparison of both therapies, we can
conclude that, despite the initially higher cost, in the near
and long term, the robot gym is more cost-effective than
the traditional one-to-one therapies.
One of the main problems in public rehabilitation set-
tings in low and middle-income countries is the avail-
ability of physical therapists and rehabilitation doctors
[84]. It is common to find a low density of health profes-
sionals in developing countries such as Mexico where,
for example, the ratio of health workers to patients is ap-
proximately 5.14 times lower than in the US [18]. The
physical therapist in a public setting in Mexico usually
spends 30–40 min per patient, which allows the therap-
ist to treat 10 to 16 patients in an 8-h working day. With
the help of the Robot Gym, a therapist could treat six
patients which could result in a maximum of 24 patients
receiving a 2 h therapy in an 8-h shift. The initial invest-
ment to set up a Robot Gym is 4 times higher than the
investment required to set-up a traditional therapy setting;
however, as showed in results, the initial expenditure is
compensated by the increased number of patients seen
per therapist when providing robotic gym therapy. Group
therapy could also offer a similar labor efficient to the ro-
botic therapy but these type of therapies were not consid-
ered in this study as it is not the standard therapy and we
did not find any public health clinic in the region offering
these type of therapies.
In the future we anticipate further revising this robotic
gym concept to be even more cost-effective and more
applicable to other low- and middle-income countries.
Conclusion
There is an increased need for effective and affordable
rehabilitation approaches that maximize functional
recovery when stroke survivors are released from the
hospital to the clinic. With the Robot Gym, we can im-
prove rehabilitation capacity and leverage technology to
reduce rehabilitation costs and maximize the utilization
of therapy personnel resources. This concept allows the
patient to receive comprehensive, intensive periods of
therapy to improve their chances of recovery and exped-
ite their return to their social and productive environ-
ment. The results of this pilot study showed that stroke
patients that received therapy using the Robot Gym had
improved functionality supporting that technology-
assisted rehabilitation is more or as efficient as trad-
itional therapy. Furthermore, the Robot Gym is a more
cost- and labor-efficient therapy option since only one
therapist is needed to supervise six patients, making it a
feasible option for countries with scarce clinical re-
sources and funding. However, the effect that working in
groups with gaming therapy in the Robot Gym setting
might have on patient motivation needs to be evaluated.
A study with a larger sample may help to further cor-
roborate our findings. The transferability of the Robot
Gym to health care settings could be further explored by
applying the concepts used in this study to evaluate the ef-
fectiveness of this type of therapy in the rehabilitation of
individuals with a wider range of functional disabilities.
Abbreviations
10MtsWT: 10 Meter walk test; 6MinWT: 6 Minute walk test; ADLs: Activities of
daily living; BBT: Box and block test; CCT: Circuit class or circuit training therapy;
CNS: Central nervous system; CT: Control group; DIF: Desarrollo Integral de la
Familia; FES: Functional electrical stimulation; IRB: Institutional Review Board;
LE-FM: Fugl-Meyer lower extremity; PHI: Protected health information; Robot
Gym: Gymnasium for robotic rehabilitation; RT: Robot intervention group;
TENs: Transcutaneous electrical nerve stimulation; TUG: Timed up and go test;
UE-FM: Fugl-Meyer upper extremity; UE-FT: Functional test for the upper
extremity
Acknowledgments
The authors gratefully acknowledge the assistance provided by the Centro de
Rehabilitación y Educación Especial (CREE)-DIF Chihuahua and its personnel,
Dr. Yuridia Rufino and OT Amalet Aranda. We appreciate the collaboration of
the senior research technicians in the CTIB, especially Erick Madrid. The authors
are grateful for the participation and dedication of all the patients involved in
this research.
Funding
This work was supported by FOMIX-CONACYT CHIH-2009-C02-127781
(Fondo Mixto Estatal del Consejo Nacional de Ciencia y Tecnologia, Combined
State Fund of the National Council of Science and Technology), CONACYT
I0015-225083 (Consejo Nacional de Ciencia y Tecnologia, National Council of
Science and Technology) and American Heart Association Grant #0635450Z.
Availability of data and materials
The dataset generated during and/or analyzed during the current study are
not publicly available because consent to make raw data public was not
obtained. However, data can be made available from the corresponding author
on reasonable request. The dataset can be made anonymous in a manner that
can easily be verified by any user of the dataset. Publication of the dataset
clearly and obviously presents minimal risk to confidentiality of study
participants. Ethics committee oversight committee at Marquette
University and at the CREE hospital can be consulted.
Bustamante Valles et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:83 Page 13 of 15
Authors’ contributions
MJ designed the original conception of the work. MJ together with KB worked
on the grant proposal, the construction of the Robot Gym, the elaboration of
the Institutional Reviews forms, and the implementation of the protocol.
KB supervised the randomized controlled trial. SM supervised all patients and
carried out tests. MDJM was in charge of patient recruitment, revising the
inclusion criteria, and follow-up consultations. MEM executed the statistical
analysis of each test. AB performed Functional Tests and supervised the health
of the patients throughout the protocol. All authors contributed intellectual
content to the manuscript and approved the final version.
Authors’ information
Michelle J. Johnson is an Assistant Professor of Physical Medicine and
Rehabilitation at the Department of Physical Medicine and Rehabilitation in
the School of Medicine at the University of Pennsylvania. She has a Ph.D. in
Mechanical Engineering with Emphasis in Robotics, Design, Controls, and
Mechatronics from Stanford University. Her research focuses on the areas of
neurorehabilitation using robotics and robot design.
Karla Bustamante is currently a Research Professor at the Instituto Tecnologico
y de Estudios Superiores de Monterrey, Campus Chihuahua, Mexico (ITESM). She
is also an Adjunct Professor at the Orthopaedic and Rehabilitation
Engineering Center at Marquette University, Milwaukee Wisconsin, USA. She
has a Ph.D. in Biomedical Engineering with emphasis in neural recordings
from University of Surrey, UK. She funded and directs the Centro de
Tecnologia e Investigacion en Biomedicina at the ITESM.
Sandra Montes is a Senior Research Assistant at the Centro de Tecnologia e
Investigacion en Biomedicina at the ITESM.
Maria Madrigal is a consultant at the Centro de Tecnologia e Investigacion en
Biomedicina at the ITESM and is an attendant Physician at the Centro de
Rehabilitacion y Educacion Especial, DIF, Mexico.
Maria Elena Martinez is a biostatistics consultant at the Centro de Tecnologia
e Investigacion en Biomedicina and a Professor at the ITESM.
Adan Burciaga is a physical therapist at the Centro de Rehabilitacion y Educacion
Especial, DIF, Mexico.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Consent has been obtained.
Ethics approval and consent to participate
The research was conducted in accordance with the Declaration of Helsinki
under the guidelines provided by the Marquette University Institutional
Review Board, which was the IRB of record. The ethics committee at CREE,
Mexico provided a consent to documents approved by the IRB of record.
The study was approved under the protocol # HR- 2110. Trial registration:
ISRCTN98578807.
Author details
1Department of Physical Medicine and Rehabilitation, University of
Pennsylvania, Philadelphia, PA, USA. 2Department of Biomedical Engineering,
University of Pennsylvania, Philadelphia, PA, USA. 3Orthopaedic and
Rehabilitation Engineering Center (OREC), Marquette University, Milwaukee,
WI, USA. 4Biomedical Engineering, ITESM, Campus Chihuahua, Chihuahua,
Chihuahua, Mexico. 5Centro de Rehabilitacion y Educacion Especial, DIF,
Chihuahua, Chihuahua, Mexico.
Received: 13 November 2015 Accepted: 26 August 2016
References
1. Feigin V, et al. Worldwide stroke incidence and early case fatality reported
in 56 population-based studies: a systematic review. Lancet Neurol.
2009;8(4):355–69.
2. Addo J, et al. Socioeconomic status and stroke: an updated review. Stroke.
2012;43(4):1186–91.
3. Mackay J, Mensah G. Atlas of heart disease and stroke. Geneva: World
Health Organization; 2004. p. 112.
4. Go A, et al. Heart Disease and Stroke Statistics – 2014 update: a report from
the American Heart Association. Circulation. 2014;129(3):e28–e292.
5. Ovbiagele B, Nguyen-huynh M. Stroke epidemiology: advancing our
understanding of disease mechanism and therapy. Neurotherapeutics.
2011;8(3):319–29.
6. Frenk Mora J, et al. Programa de Acción: Enfermedades Cardiovasculares e
Hipertensión Arterial. México: Secretaria de Salud, SSA; 2001. p. 21–33. ISBN:
970-721-002-8.
7. Consejo Nacional de Poblacion, CONAPO. Proyecciones de la Población de
México por entidades federativas 2010–2030. México: Secretaria de
Gobernacion, SEGOB; 2013. Reviewed from http://www.conapo.gob.mx/es/
CONAPO/Proyecciones_Datos.
8. INEGI, I.N.d.E.y.G. Estadísticas a propósito del Día de Muertos. Aguascalientes:
Instituto Nacional de Estadística y Geografía; 2013.
9. Mathers C, Loncar D. Projections of global mortality and burden of disease
from 2002 to 2030. PLoS Med. 2006;3(11):2011–30.
10. Brault M, et al. Prevalence and most common causes of disability among
adults - United States, 2005. MMWR Morb Mortal Wkly Rep. 2009;58(16):421–6.
11. Gresham G, Duncan P, Stason W. Post-stroke rehabilitation. In: Clinical
practice guidelines. AHCPR Publication; 1995. p. 248.
12. Semrau J, et al. Robotic identification of kinesthetic deficits after stroke.
Stroke. 2013;44:3414–21.
13. Krakauer J. Arm function after stroke: from physiology to recovery. Semin
Neurol. 2005;25(4):385–95.
14. Mensah G, Norrving B, Feigin VL. The Global Burden of stroke.
Neuroepidemiology. 2015;45:143–5.
15. Skolarus L, Morgenstern L. Deprived of a good stroke outcome. Stroke.
2015;46:612–3.
16. Ovbiagele B, et al. Forecasting the future of stroke in the United States: a
policy statement from the American Heart Association and American Stroke
Association. Stroke. 2013;44(8):2361–75.
17. Jiménez-Cruz A, Bacardi-Gascon M. The fattening burden of type 2 diabetes
on Mexicans: projections from early growth to adulthood. Diabetes Care.
2004;27(5):1213–5.
18. World Health Organization, W.H.O. In: Vita-Finzi L, Campanini B, editors. The
World Health Report 2006: working together for health. France: World
Health Organization; 2006.
19. Frost L, Reich R. Creating access to health technologies in poor countries.
Health Aff. 2009;28(4):962–73.
20. World Health Organization, WHO. Medical Devices: Managing the Mismatch:
An Outcome of the Priority Medical Devices Project. Essential Medicines and
Health Products Information Portal A World Health Organization resource:
First WHO Global Forum on Medical Devices. 2010. p. 22–41.
21. Aziz N, et al. Therapy-based rehabilitation services for patients living at home
more than one year after stroke. Cochrane Database Syst Rev. 2008;2:CD005952.
22. Patten C, Lexell J, Brown H. Weakness and strength training in persons with
poststroke hemiplegia: rationale, method, and efficacy. J Rehabil Res Dev.
2004;41(3A):293–312.
23. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic
review. Lancet Neurol. 2009;8(8):741–54.
24. Pollock A, et al. Physical rehabilitation approaches for the recovery of
function and mobility following stroke. Cochrane Database Syst Rev. 2014;4.
25. Kwakkel G, Kollen BJ, Wagenaar R. Therapy impact on functional recovery in
stroke rehabilitation : a critical review of the literature. Physiotherapy.
1999;85(7):377–91.
26. Hesse S, et al. Effect on arm function and cost of robot-assisted group
therapy in subacute patients with stroke and a moderately to severely
affected arm: a randomized controlled trial. Clin Rehabil. 2014;28(7):637–47.
27. Lo A, et al. Robot-assisted therapy for long-term upper-limb impairment
after stroke. N Engl J Med. 2010;362(19):1772–83.
28. Loureiro R, et al. Advances in upper limb stroke rehabilitation: a technology
push. Med Biol Eng Comput. 2011;49(10):1103–18.
29. Mehrholz J, et al. Electromechanical and robot-assisted arm training for
improving generic activities of daily living, arm function, and arm muscle
strength after stroke. Cochrane Database Syst Rev. 2012;6:CD006876.
30. Riener R, et al. Patient-cooperative strategies for robot-aided treadmill
training: first experimental results. IEEE Trans Neural Syst Rehabil Eng.
2005;13(3):380–94.
31. Timmermans A, et al. Technology-assisted training of arm-hand skills in
stroke: concepts on reacquisition of motor control and therapist guidelines
for rehabilitation technology design. J Neuroeng Rehabil. 2009;6:1.
32. Wagner T, et al. An economic analysis of robot-assisted therapy for
long-term upper-limb impairment after stroke. Stroke. 2011;42(9):2630–2.
Bustamante Valles et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:83 Page 14 of 15
33. Nef T, et al. Effects of arm training with the robotic device ARMin I in
chronic stroke: three single cases. Neurodegener Dis. 2009;6(5–6):240–51.
34. Pehlivan A, Celik O, O’Malley M. Mechanical design of a distal arm
exoskeleton for stroke and spinal cord injury rehabilitation. In: IEEE
International Conference on Rehabilitation Robotics. Zurich: ETH Zurich
Science City; 2011.
35. Housman S, Scott K, Reinkensmeyer D. A randomized controlled trial of
gravity-supported, computer-enhanced arm exercise for individuals with
severe hemiparesis. Neurorehabil Neural Repair. 2009;23(5):505–14.
36. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet.
2011;377(9778):1693–702.
37. Lum P, et al. Robot-assisted movement training compared with
conventional therapy techniques for the rehabilitation of upper-limb motor
function after stroke. Arch Phys Med Rehabil. 2002;83(7):952–9.
38. Hesse S, et al. Combined transcranial direct current stimulation and
robot-assisted arm training in Subacute stroke patients: an exploratory,
randomized multicenter trial. Neurorehabil Neural Repair. 2011;25(9):838–46.
39. Hesse S, et al. Mechanical arm trainer for the treatment of the severely
affected arm after a stroke: a single-blinded randomized trial in two centers.
Am J Phys Med Rehabil. 2008;87(10):779–88.
40. Seitz R, et al. Monitoring of visuomotor coordination in healthy subjects and
patients with stroke and Parkinson’s disease: an application study using the
PABLOR-device. Int J Neurorehabil. 2014;1:113.
41. Linder S, et al. Incorporating robotic-assisted telerehabilitation in a home
program to improve arm function following stroke: a case study. J Neurol
Phys Ther. 2014;37(3):125–32.
42. Dovat L, et al. A Haptic Knob for Rehabilitation of Stroke Patients. In:
International Conference on Intelligent Robots and Systems. Beijing: IEEE/
RSJ International Conference on; 2006.
43. Buschfort R, et al. Arm studio to intensify the upper limb rehabilitation after
stroke: concept, acceptance, utilization and preliminary clinical results.
J Rehabil Med. 2010;42(4):310–4.
44. Yong Joo L, et al. A feasibility study using interactive commercial off-the-shelf
computer gaming in upper limb rehabilitation in patients after stroke.
J Rehabil Med. 2010;42(5):437–41.
45. Johnson M, Montes S, Bustamante K. TheraDrive in a robot gym: toward
stroke rehabilitation beyond inpatient rehabilitation settings in USA and
Mexico. In: Special Session on Technology for People with Disorders of the
Upper an the Lower Limbs - TPDULL 2014. Loire Valley: ESEO, Angers; 2014.
46. Johnson M, et al. TheraDrive: a new stroke therapy concept for home-based,
computer-assisted motivating rehabilitation. In: 26th Annual International
Conference of the IEEE EMBS. San Francisco: IEEE; 2004. p. 4844–7.
47. Ruparel R, et al. Evaluation of the TheraDrive System for Robot/Computer
Assisted Motivating Rehabilitation After Strok. In: 31st Annual International
Conference of the IEEE EMBS. Minneapolis: IEEE; 2009. p. 811–4.
48. Hervada-Vidal X, et al. Epidat 3.0: Programa para el análisis epidemiológico
de datos tabulados. Rev Esp Salud Publica. 2004;78(2):277–80.
49. Yesavage J, et al. Development and validation of a geriatric depression
screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17(1):13–24.
50. Schwartz S, et al. Relationship between two measures of upper extremity
strength: manual muscle test compared to hand-held myometry. Arch Phys
Med Rehabil. 1992;73(11):1063–8.
51. Bohannon R, Smith M. Interrater reliability of a modified Ashworth scale of
muscle spasticity. Phys Ther. 1987;62(2):206–7.
52. Agency for Health Care Policy and Research, A.H.C.P.R. Acute pain
management: operative or medical procedures and trauma. In: Clinical
Practice Guideline No. 1. Rockville: AHCPR Publication; 1992. p. 116–7.
53. Scott J, Huskisson E. Graphic representation of pain. Pain. 1976;2(2):175–84.
54. Alon G, Ring H. Gait and hand function enhancement following training
with a multi-segment hybrid-orthosis stimulation system in stroke patients.
J Stroke Cerebrovasc Dis. 2003;12(5):209–16.
55. Hausdorf J, Ring H. The effect of the NESS L300 neuroprosthesis on gait
stability and symmetry. J Neurol Phys Ther. 2006;30(4):198.
56. Kamps A, Schüle K. Cyclic movement training of lower extremities in stroke
patients. Neurol Rehabil. 2005;11(3):126–34.
57. Diserens K, et al. Effect of repetitive arm cycling following botulinum toxin
injection for poststroke spasticity: evidence from fMRI. Neurorehabil Neural
Repair. 2010;24(8):753–62.
58. Rohling M, et al. Effectiveness of cognitive rehabilitation following acquired
brain injury: a meta-analytic re-examination of Cicerone et al.’s (2000, 2005)
systematic reviews. Neuropsychology. 2009;23(1):20–40.
59. Duncan P, Propst M, Nelson S. Reliability of the Fugl-Meyer assessment of
sensorimotor recovery following cerebrovascular accident. Phys Ther.
1983;63(10):1606–10.
60. Fugl-Meyer A, et al. The post-stroke hemiplegic patient. 1. a method for
evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13–31.
61. Gladstone D, Danells C, Black S. The fugl-meyer assessment of motor
recovery after stroke: a critical review of its measurement properties.
Neurorehabil Neural Repair. 2002;16(3):232–40.
62. Wilson D, Baker L, Craddock J. Functional test for the hemiparetic upper
extremity. Am J Occup Ther. 1984;38(3):159–64.
63. Mathiowetz V, et al. Adult norms for the Box and Block Test of manual
dexterity. Am J Occup Ther. 1985;39(6):386–91.
64. Duncan P, et al. Protocol for the Locomotor Experience Applied Post-stroke
(LEAPS) trial: a randomized controlled trial. BMC Neurol. 2007;7:39.
65. Perry J, et al. Classification of walking handicap in the stroke population.
Stroke. 1995;26(6):982–7.
66. Tilson J, et al. Meaningful gait speed improvement during the first
60 days poststroke: minimal clinically important difference. Phys Ther.
2010;90(2):196–208.
67. Guyatt G, et al. The 6-minute walk: a new measure of exercise capacity in
patients with chronic heart failure. Can Med Assoc J. 1985;132(8):919–23.
68. Laboratories, A.C.o.P.S.f.C.P.F. ATS statement: guidelines for the six-minute
walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.
69. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional
mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.
70. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.
Hillsdale: L. Erlbaum Associates; 1988. p. 567.
71. Secretaria de Salud S. Tabulador Autorizado Rama Medica, Paramedica y
Grupo Afin. 2012.
72. Wevers L, et al. Effects of task-oriented circuit class training on walking
competency after stroke: a systematic review. Stroke. 2009;40(7):2450–9.
73. English C, Hillier S. Circuit class therapy for improving mobility after stroke.
Cochrane Database Syst Rev. 2010;7:CD007513.
74. English C, et al. Circuit class therapy versus individual physiotherapy
sessions during inpatient stroke rehabilitation: a controlled trial. Arch Phys
Med Rehabil. 2007;88(8):955–63.
75. Horne-Moyer H, et al. The use of electronic games in therapy: a review with
clinical implications. Curr Psychiatry Rep. 2014;16:520.
76. Fleg J, Lakatta E. Role of muscle loss in the age-associated reduction in VO2
max. J Appl Physiol. 1988;65(3):1147–51.
77. Tolep K, Kelsen S. Effect of aging on respiratory skeletal muscles. Clin Chest
Med. 1993;14(3):363–78.
78. Bagg S, Pombo A, Hopman W. Effect of age on functional outcomes after
stroke rehabilitation. Stroke. 2002;33(1):179–86.
79. Kugler C, et al. Does age influence early recovery from ischemic stroke? A
study from the Hessian Stroke Data Bank. J Neurol. 2003;250(6):676–81.
80. Brokaw E, et al. Robotic therapy provides a stimulus for upper limb motor
recovery after stroke that is complementary to and distinct from
conventional therapy. Neurorehabil Neural Repair. 2013;28(4):367–76.
81. Norouzi-Gheidari N, Archambault P, Fung J. Effects of robot-assisted therapy
on stroke rehabilitation in upper limbs: systematic review and meta-analysis
of the literature. J Rehabil Res Dev. 2012;49(4):479–96.
82. Prange G, et al. Systematic review of the effect of robot-aided therapy on
recovery of the hemiparetic arm after stroke. J Rehabil Res Dev. 2006;
43(2):171–84.
83. Stein J, et al. Comparison of two techniques of robot-aided upper limb
exercise training after stroke. Am J Phys Med Rehabil. 2004;83(9):720–8.
84. World Health Organization, WHO. Monitoring human resources for
health-related rehabilitation services, in Spotlight: on health workforce
statistics. Department of Human Resources for Health. Geneva: World
Health Organization; 2009.
85. Boutron I, Moher D, Altman D, Schulz K, Group RPftC. Methods and
processes of the CONSORT group: example of an extension for trials
assessing nonpharmacologic treatments. Ann Intern Med.
2008;148(4):W60–6.
Bustamante Valles et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:83 Page 15 of 15
